Hartaj Singh
Stock Analyst at Oppenheimer
(0.81)
# 2115
Out of 5,328 analysts
131
Total ratings
42.35%
Success rate
-5.76%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
GILD Gilead Sciences | Maintains: Outperform | 132 125 | 103.48 | 20.8% | 14 | Apr 25, 2025 | |
SPRB Spruce Biosciences | Downgrades: Perform | n/a | n/a | n/a | 6 | Dec 11, 2024 | |
ATXS Astria Therapeutics | Maintains: Outperform | 26 28 | 5.12 | 446.88% | 6 | Nov 14, 2024 | |
REGN Regeneron Pharmaceut... | Maintains: Outperform | 1150 1000 | 586.15 | 70.6% | 8 | Nov 6, 2024 | |
UTHR United Therapeutics | Maintains: Outperform | 575 600 | 293.04 | 104.75% | 7 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 550 540 | 500.59 | 7.87% | 14 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 8 | Sep 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 10 | 1.6 | 525% | 5 | Jun 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 60 | 2.04 | 2841.18% | 5 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 11 | n/a | n/a | 3 | May 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 180 | 63.08 | 185.35% | 9 | May 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 | 2.17 | 314.75% | 4 | Apr 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | n/a | n/a | n/a | 2 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 40 | 1.89 | 2016.4% | 4 | Mar 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 9.12 | 141.23% | 1 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 25 | n/a | n/a | 3 | Oct 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 16 | n/a | n/a | 3 | Sep 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 55 | n/a | n/a | 3 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 4 | Jul 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Apr 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Oct 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | n/a | n/a | 1 | Apr 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 30 | n/a | n/a | 3 | Mar 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 42 | n/a | n/a | 3 | Feb 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 2 | Jul 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 4 | Mar 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 650 | 1.6 | 40525% | 1 | Nov 1, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | Jun 12, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 30 | 25.01 | 19.95% | 1 | Jan 26, 2018 |